AnaptysBio Inc buy Guggenheim
Start price
18.12.25
/
50%
€40.20
Target price
18.12.26
-
Performance (%)
40.55%
Price
26.03.26
€56.00
Summary
This prediction is currently active. With a performance of 40.55% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 0.901% | 0.901% |
| iShares Core DAX® | -1.742% | -10.677% |
| iShares Nasdaq 100 | -2.583% | -3.319% |
| iShares Nikkei 225® | -1.165% | -9.362% |
| iShares S&P 500 | -1.422% | -3.762% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat